<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Insiders Snapping Up Steak 'n Shake and Pharmacyclics]]></title><link>http://www.bloggingstocks.com/2010/06/28/insiders-snapping-up-steak-n-shake-and-pharmacyclics/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2010/06/28/insiders-snapping-up-steak-n-shake-and-pharmacyclics/</guid><comments>http://www.bloggingstocks.com/2010/06/28/insiders-snapping-up-steak-n-shake-and-pharmacyclics/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/insiders/" rel="tag">Insiders</a>, <a href="http://www.bloggingstocks.com/category/stocks-to-buy/" rel="tag">Stocks to Buy</a></p><img vspace="4" hspace="4" border="1" align="right" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2010/03/snslogo.gif"  alt="Steak 'n Shake Biglari" />If you are looking for clues telling you which stocks have a good chance of increasing in value, you might want consider watching where insiders are putting their money. After all, talk is cheap, but when insiders put their own money on the line, you should sit up and take note.<br />
<br />
Biglari Holdings Inc. (<a href="http://www.dailyfinance.com/quotes/brainhunter-inc-com-npv/bh/tor" class="inlinked">BH</a>) -- parent company of Steak 'n Shake -- topped the insider-buying charts for the week ending June 25 as insiders snapped up 27,834 shares of company stock at a market value of $8,871,287. During the past six months, insiders have increased their overall holdings in the company by 0.27% and now own 7.81% of BH stock.<br />
<br />
Pharmacyclics Inc (<a href="http://www.dailyfinance.com/quotes/pharmacyclics-inc/pcyc/nas" class="inlinked">PCYC</a>) was not far behind, with insiders buying 1,075,270 shares at a market value of $7,000,008. Insiders now own 26.08% of the company's stock after decreasing their overall holdings by 0.67% during the past six months.<p><a href="http://www.bloggingstocks.com/2010/06/28/insiders-snapping-up-steak-n-shake-and-pharmacyclics/" rel="bookmark">Continue reading <em>Insiders Snapping Up Steak 'n Shake and Pharmacyclics</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2010/06/28/insiders-snapping-up-steak-n-shake-and-pharmacyclics/">Insiders Snapping Up Steak 'n Shake and Pharmacyclics</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Mon, 28 Jun 2010 16:20:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2010/06/28/insiders-snapping-up-steak-n-shake-and-pharmacyclics/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/19533850/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2010/06/28/insiders-snapping-up-steak-n-shake-and-pharmacyclics/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>bfs</category><category>bh</category><category>biglari holdings</category><category>inthenews</category><category>mrv communications</category><category>mrvc</category><category>nav</category><category>navistar</category><category>pcyc</category><category>pharmacyclics</category><category>saul centers</category><category>steak n shake</category><dc:creator><![CDATA[Wade Hansen]]></dc:creator><pubDate>Mon, 28 Jun 2010 16:20:00 EST</pubDate></item><item><title><![CDATA[Analyst Calls: AMD, BHI, CSIQ, INTC, ITMN, MRK, MYGN, PPS, TXN ...]]></title><link>http://www.bloggingstocks.com/2010/05/05/analyst-calls-amd-intc-itmn-mrk-mygn-txn/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2010/05/05/analyst-calls-amd-intc-itmn-mrk-mygn-txn/</guid><comments>http://www.bloggingstocks.com/2010/05/05/analyst-calls-amd-intc-itmn-mrk-mygn-txn/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/analyst-reports/" rel="tag">Analyst Reports</a>, <a href="http://www.bloggingstocks.com/category/analyst-upgrades-and-downgrades/" rel="tag">Analyst Upgrades and Downgrades</a>, <a href="http://www.bloggingstocks.com/category/intc/" rel="tag">Intel (INTC)</a>, <a href="http://www.bloggingstocks.com/category/mrk/" rel="tag">Merck and Co (MRK)</a>, <a href="http://www.bloggingstocks.com/category/txn/" rel="tag">Texas Instruments (TXN)</a>, <a href="http://www.bloggingstocks.com/category/analyst-initiations/" rel="tag">Analyst Initiations</a></p><p><a href="http://www.theflyonthewall.com"><img hspace="4" border="1" align="right" vspace="4" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2010/05/flywall_final_logo_mini.gif" alt="" /></a><strong>Analyst Upgrades</strong></p>
<ul>
    <li>Citigroup upgraded Baker Hughes (<a class="inlinked" href="http://www.dailyfinance.com/quotes/baker-hughes-incorporated/bhi/nys">BHI</a>) to hold from sell following the company's Q1 results.</li>
    <li>Auriga upgraded Canadian Solar (<a class="inlinked" href="http://www.dailyfinance.com/quotes/canadian-solar-inc-common-shares/csiq/nas">CSIQ</a>) to buy from hold as it believes the company's negative preannouncement on April 20 removes a downside catalyst. Despite upgrading, the firm lowered its target for shares to $21 from $25.</li>
    <li>Deutsche Bank upgraded Post Properties (<a class="inlinked" href="http://www.dailyfinance.com/quotes/post-properties-inc/pps/nys">PPS</a>) to hold from sell following the company's Q1 results. The firm upped its target for shares to $27 from $16.</li>
    <li>Wright Express (<a class="inlinked" href="http://www.dailyfinance.com/quotes/wright-express-corporation/wxs/nys">WXS</a>) was upgraded to buy from neutral at Goldman.</li>
    <li>Nvidia (<a class="inlinked" href="http://www.dailyfinance.com/quotes/nvidia-corporation/nvda/nas">NVDA</a>) coverage was assumed with a buy from hold at ThinkEquity.</li>
    <li>Elan (<a class="inlinked" href="http://www.dailyfinance.com/quotes/elan-corporation-plc/eln/nys">ELN</a>) was upgraded to neutral from sell at UBS.</li>
</ul><p><a href="http://www.bloggingstocks.com/2010/05/05/analyst-calls-amd-intc-itmn-mrk-mygn-txn/" rel="bookmark">Continue reading <em>Analyst Calls: AMD, BHI, CSIQ, INTC, ITMN, MRK, MYGN, PPS, TXN ...</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2010/05/05/analyst-calls-amd-intc-itmn-mrk-mygn-txn/">Analyst Calls: AMD, BHI, CSIQ, INTC, ITMN, MRK, MYGN, PPS, TXN ...</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Wed, 05 May 2010 11:00:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2010/05/05/analyst-calls-amd-intc-itmn-mrk-mygn-txn/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/19465488/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2010/05/05/analyst-calls-amd-intc-itmn-mrk-mygn-txn/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>ABM</category><category>AMD</category><category>analyst upgrades</category><category>BHI</category><category>COCO</category><category>CSIQ</category><category>downgrades</category><category>ELN</category><category>initiations</category><category>INTC</category><category>Intel</category><category>inthenews</category><category>ITMN</category><category>Merck</category><category>MRK</category><category>MYGN</category><category>Myriad</category><category>NVDA</category><category>PCYC</category><category>PPS</category><category>Texas Instruments</category><category>TXN</category><category>WBMD</category><category>WXS</category><dc:creator><![CDATA[Eric Buscemi]]></dc:creator><pubDate>Wed, 05 May 2010 11:00:00 EST</pubDate></item><item><title><![CDATA[Analyst Upgrades, Downgrades and Initiations: BKC, CAH, DGX, FII, MAN, URBN, WMT ...]]></title><link>http://www.bloggingstocks.com/2010/01/29/analyst-upgrades-downgrades-and-initiations/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2010/01/29/analyst-upgrades-downgrades-and-initiations/</guid><comments>http://www.bloggingstocks.com/2010/01/29/analyst-upgrades-downgrades-and-initiations/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/analyst-reports/" rel="tag">Analyst Reports</a>, <a href="http://www.bloggingstocks.com/category/analyst-upgrades-and-downgrades/" rel="tag">Analyst Upgrades and Downgrades</a>, <a href="http://www.bloggingstocks.com/category/wmt/" rel="tag">Wal-Mart (WMT)</a>, <a href="http://www.bloggingstocks.com/category/analyst-initiations/" rel="tag">Analyst Initiations</a></p><p><a href="http://www.theflyonthewall.com"><img hspace="4" vspace="4" border="1" align="right" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2010/01/flywall_final_logo_mini.gif" alt="" /></a><strong>Analyst Upgrades</strong></p>
<ul>
    <li>Goldman upgraded Walmart (<a href="http://www.dailyfinance.com/quotes/wal-mart-stores-inc/wmt/nys">WMT</a>) to buy from neutral, citing compelling valuation, margin expansion and expense control. The firm has a $60 target on the stock.</li>
    <li>FBR Capital upgraded Urban Outfitters (<a href="http://www.dailyfinance.com/quotes/urban-outfitters-inc/urbn/nas">URBN</a>) to outperform from market perform on valuation and its belief that sustainable positive comp trends will return in 2010. The firm maintains a $35 price target on shares.</li>
    <li>JPMorgan upgraded Manpower (<a href="http://www.dailyfinance.com/quotes/manpower-inc-wi/man/nys">MAN</a>) to overweight from neutral. The firm cites valuation and improving temp fundamentals in the U.S. and France for the upgrade and has a $70 price target on the stock.</li>
    <li>Arena Resources (<a href="http://www.dailyfinance.com/quotes/arena-resources-inc/ard/nys">ARD</a>) was upgraded to buy from neutral at SunTrust.</li>
    <li>C.R. Bard (<a href="http://www.dailyfinance.com/quotes/bard-c-r-inc/bcr/nys">BCR</a>) was upgraded to neutral from underweight at Piper Jaffray.</li>
    <li>Cardinal Health (<a href="http://www.dailyfinance.com/quotes/cardinal-health-incorporated/cah/nys">CAH</a>) was upgraded to overweight from market weight at Thomas Weisel.</li>
</ul><p><a href="http://www.bloggingstocks.com/2010/01/29/analyst-upgrades-downgrades-and-initiations/" rel="bookmark">Continue reading <em>Analyst Upgrades, Downgrades and Initiations: BKC, CAH, DGX, FII, MAN, URBN, WMT ...</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2010/01/29/analyst-upgrades-downgrades-and-initiations/">Analyst Upgrades, Downgrades and Initiations: BKC, CAH, DGX, FII, MAN, URBN, WMT ...</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Fri, 29 Jan 2010 12:00:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2010/01/29/analyst-upgrades-downgrades-and-initiations/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/19337478/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2010/01/29/analyst-upgrades-downgrades-and-initiations/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>ABFS</category><category>analyst upgrades</category><category>ARD</category><category>AVNR</category><category>BCR</category><category>BKC</category><category>BMI</category><category>BTE</category><category>CAH</category><category>CERN</category><category>DGX</category><category>downgrades</category><category>FII</category><category>initiations</category><category>inthenews</category><category>MAN</category><category>PAR</category><category>PCYC</category><category>STI</category><category>URBN</category><category>Wal-Mart</category><category>Walmart</category><category>WBSN</category><category>WMT</category><dc:creator><![CDATA[Eric Buscemi]]></dc:creator><pubDate>Fri, 29 Jan 2010 12:00:00 EST</pubDate></item><item><title><![CDATA[The week's top biotech gainers]]></title><link>http://www.bloggingstocks.com/2008/06/06/the-weeks-top-biotech-gainers/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2008/06/06/the-weeks-top-biotech-gainers/</guid><comments>http://www.bloggingstocks.com/2008/06/06/the-weeks-top-biotech-gainers/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/major-movement/" rel="tag">Major Movement</a>, <a href="http://www.bloggingstocks.com/category/industry/" rel="tag">Industry</a></p><p>This was quite a week in biotechnology. You had a major premium buyout and had much data come out from the American Society of Clinical Oncology (ASCO) and others. This is far from all of the movers, but it is a brief summary of the major gainers from <a href="http://www.BioHealthInvestor.com">BioHealthInvestor.com</a> showing how large some moves were in biotechnology this week.</p>
<p><a href="http://finance.aol.com/quotes/acorda-therapeutics-inc/acor/nas">Acorda Therapeutics Inc.</a> (NASDAQ: <a href="http://finance.aol.com/quotes/acorda-therapeutics-inc/acor/nas">ACOR</a>) had a great week after it announced positive data from a second Phase III study of its Fampridine-SR for patients' walking abilities who suffer from multiple sclerosis (MS). <a href="http://www.biohealthinvestor.com/2008/06/acorda-score-great-phase-iii-data-acor.html">FULL DETAILS</a></p>
<p><a href="http://finance.aol.com/quotes/auxilium-pharmaceuticals-inc/auxl/nas">Auxilium Pharmaceuticals Inc.</a> (NASDAQ: <a href="http://finance.aol.com/quotes/auxilium-pharmaceuticals-inc/auxl/nas">AUXL</a>) was a strange stock this week. The company reported great news but shares slid before the market figured out it had misinterpreted news in the company. <a href="http://www.biohealthinvestor.com/2008/06/auxilium-diabetes-drug-meets-endpoints-yet-shares-slide-auxl.html">INITIAL DETAILS</a></p>
<p><a href="http://finance.aol.com/quotes/inspire-pharmaceuticals-inc/isph/nas">Inspire Pharmaceuticals Inc.</a> (NASDAQ: <a href="http://finance.aol.com/quotes/inspire-pharmaceuticals-inc/isph/nas">ISPH</a>) saw a surge after it reached its primary endpoint in Phase III trial of Denufosol for Cystic Fibrosis. <a href="http://www.biohealthinvestor.com/2008/06/inspire-scores-on-cystic-fibrosis-phase-iii-isph.html">FULL DETAILS</a></p><p><a href="http://www.bloggingstocks.com/2008/06/06/the-weeks-top-biotech-gainers/" rel="bookmark">Continue reading <em>The week's top biotech gainers</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2008/06/06/the-weeks-top-biotech-gainers/">The week's top biotech gainers</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Fri, 06 Jun 2008 16:55:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2008/06/06/the-weeks-top-biotech-gainers/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1218125/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2008/06/06/the-weeks-top-biotech-gainers/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>ACOR</category><category>AUXL</category><category>Biotech</category><category>inthenews</category><category>ISPH</category><category>LGND</category><category>ONCY</category><category>PCYC</category><category>SQNM</category><category>TRCA</category><dc:creator><![CDATA[Jon Ogg]]></dc:creator><pubDate>Fri, 06 Jun 2008 16:55:00 EST</pubDate></item><item><title><![CDATA[Market highlights for next week: Happy New Year!]]></title><link>http://www.bloggingstocks.com/2007/12/28/market-highlights-for-next-week-happy-new-year/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2007/12/28/market-highlights-for-next-week-happy-new-year/</guid><comments>http://www.bloggingstocks.com/2007/12/28/market-highlights-for-next-week-happy-new-year/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/before-the-bell/" rel="tag">Before the Bell</a>, <a href="http://www.bloggingstocks.com/category/f/" rel="tag">Ford Motor (F)</a>, <a href="http://www.bloggingstocks.com/category/gm/" rel="tag">General Motors (GM)</a></p><a href="http://www.theflyonthewall.com/splashPage.php?source=AOL"><img vspace="4" hspace="4" border="1" align="right" alt="" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2007/12/fly-logo-(aol).gif" /></a>Monday, December 31<br />
<ul>
    <li>PDUFA date for <a href="http://finance.aol.com/quotes/pharmacyclics-inc/pcyc/nas">Pharmacyclics</a> (NASDAQ: <a href="http://finance.aol.com/quotes/pharmacyclics-inc/pcyc/nas">PCYC</a>)' Xcytrin for treatment of non-small cell lung cancer patients with brain metastases.</li>
</ul>
Tuesday, January 1<br />
<ul>
    <li>Markets closed for New Year's holiday.</li>
</ul>
Wednesday, January 2<br />
<ul>
    <li>PDUFA date for <a href="http://finance.aol.com/quotes/skyepharma-plc/skyey/nao">SkyePharmaceuticals</a> (OTC: <a href="http://finance.aol.com/quotes/skyepharma-plc/skyey/nao">SKYEY</a>) and <a href="http://finance.aol.com/quotes/sciele-pharma-inc/scrx/nas">Sciele Pharmaceuticals</a> (NASDAQ: <a href="http://finance.aol.com/quotes/sciele-pharma-inc/scrx/nas">SCRX</a>) Sular Formulation for Hypertension. The FDA extended the PDUFA Date from November 2, 2007. </li>
</ul>
Thursday, January 3<br />
<ul>
    <li><a href="http://finance.aol.com/quotes/ford-motor-company/f/nys">Ford Motor Company</a> (NYSE: <a href="http://finance.aol.com/quotes/ford-motor-company/f/nys">F</a>) to report monthly sales at 1pm</li>
    <li><a href="http://finance.aol.com/quotes/general-motors-corporation/gm/nys">General Motors</a> (NYSE: <a href="http://finance.aol.com/quotes/general-motors-corporation/gm/nys">GM</a>) to report monthly sales at 2pm.</li>
    <li><a href="http://finance.aol.com/quotes/angiodynamics-inc/ango/nas">AngioDynamics</a> (NASDAQ: <a href="http://finance.aol.com/quotes/angiodynamics-inc/ango/nas">ANGO</a>) to report Q2 earnings; conference call at 4:30pm.</li>
</ul>
Friday, January 4<br />
<ul>
    <li><a href="http://finance.aol.com/quotes/millennium-pharmaceuticals-inc/mlnm/nas">Millennium Pharmaceuticals</a> (NASDAQ: <a href="http://finance.aol.com/quotes/millennium-pharmaceuticals-inc/mlnm/nas">MLNM</a>) to provide guidance at 8am.</li>
    <li><a href="http://finance.aol.com/quotes/checkpoint-systems-inc/ckp/nys">Checkpoint Systems</a> (NYSE: <a href="http://finance.aol.com/quotes/checkpoint-systems-inc/ckp/nys">CKP</a>) to provide guidance at 10am.</li>
    <li>Federal Reserve Govenor Kohn to provide keynote speech at the AEA Annual Meeting in New Orleans at 11:45am.</li>
</ul><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2007/12/28/market-highlights-for-next-week-happy-new-year/">Market highlights for next week: Happy New Year!</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Fri, 28 Dec 2007 16:00:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2007/12/28/market-highlights-for-next-week-happy-new-year/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1072708/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/12/28/market-highlights-for-next-week-happy-new-year/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>(NYSE: GM</category><category>(nyse:Gm</category><category>AngioDynamics</category><category>ANGO</category><category>Checkpoint Systems</category><category>CheckpointSystems</category><category>CKP</category><category>F</category><category>Ford Motor Company</category><category>FordMotorCompany</category><category>Millennium Pharmaceuticals</category><category>MillenniumPharmaceuticals</category><category>MLNM</category><category>PCYC</category><category>Pharmacyclics</category><category>Sciele Pharmaceuticals</category><category>ScielePharmaceuticals</category><category>SCRX</category><category>SkyePharmaceuticals</category><category>SKYEY</category><dc:creator><![CDATA[Eric Buscemi]]></dc:creator><pubDate>Fri, 28 Dec 2007 16:00:00 EST</pubDate></item></channel></rss>
